Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

CorMedix (CRMD) Gross Profit: 2010-2024

Historic Gross Profit for CorMedix (CRMD) over the last 14 years, with Dec 2024 value amounting to $40.3 million.

  • CorMedix's Gross Profit rose 764.30% to $93.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $198.5 million, marking a year-over-year increase of 1839.33%. This contributed to the annual value of $40.3 million for FY2024, which is 117552.87% up from last year.
  • As of FY2024, CorMedix's Gross Profit stood at $40.3 million, which was up 117,552.87% from -$34,296 recorded in FY2023.
  • In the past 5 years, CorMedix's Gross Profit registered a high of $40.3 million during FY2024, and its lowest value of -$34,296 during FY2023.
  • For the 3-year period, CorMedix's Gross Profit averaged around $13.4 million, with its median value being $61,674 (2022).
  • Its Gross Profit has fluctuated over the past 5 years, first plummeted by 155.61% in 2023, then soared by 117,552.87% in 2024.
  • CorMedix's Gross Profit (Yearly) stood at $34,385 in 2020, then grew by 22.14% to $41,998 in 2021, then spiked by 46.85% to $61,674 in 2022, then plummeted by 155.61% to -$34,296 in 2023, then surged by 117,552.87% to $40.3 million in 2024.